טוען...
A novel inflammatory biomarker, GlycA, associates with disease activity in rheumatoid arthritis and cardio-metabolic risk in BMI-matched controls
BACKGROUND: RA and CVD both have inflammation as part of the underlying biology. Our objective was to explore the relationships of GlycA, a measure of glycosylated acute phase proteins, with inflammation and cardiometabolic risk in RA, and explore whether these relationships were similar to those fo...
שמור ב:
הוצא לאור ב: | Arthritis Res Ther |
---|---|
Main Authors: | , , , , , , , , , , |
פורמט: | Artigo |
שפה: | Inglês |
יצא לאור: |
BioMed Central
2016
|
נושאים: | |
גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4828830/ https://ncbi.nlm.nih.gov/pubmed/27067270 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-016-0982-5 |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|